Locations:

Tag: anticoagulation

June 12, 2024/Neurosciences/Cerebrovascular

Early Therapeutic Anticoagulation After Cranial Surgery Raises Risk of Intracranial Hemorrhage

Case series links catastrophic outcomes to therapy initiation within 48 hours post-procedure

23-HVI-4469361_atrial-fibrillation_650x450

February 2, 2024/Heart, Vascular and Thoracic/Electrophysiology

Atrial Fibrillation Guideline Introduces Stage-Based Classification, Stresses Early Rhythm Control

ACC/AHA panel also upgrades catheter ablation recommendations

May 31, 2023/Heart, Vascular and Thoracic/Heart Valve Disease

PROACT Xa: Apixaban Is Not a Safe Warfarin Substitute With Mechanical Aortic Valve

Details released from the trial halted due to excessive thromboembolic events

December 8, 2022/Geriatrics

Left Atrial Appendage Closure Is Safe to Consider Even in the Very Elderly

Large database analysis finds no rise in in-hospital mortality relative to younger patients

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 9, 2021/Heart, Vascular and Thoracic/Heart Valve Disease

Analysis Reveals Considerable Off-Label Use of Direct Oral Anticoagulants After Heart Valve Replacement

Investigators urge caution until more data accrue

August 26, 2020/Pediatrics/Patient Care & Management

Cleveland Clinic Children’s ECMO Honored for Excellence in Life Support

Program wins gold ELSO award

20-HVI-1910656-CQD-Tall-Rounds-COVID-Thrombotic-Complications

August 11, 2020/COVID-19

Thrombotic Complications of COVID-19: Principles for Treatment and Prevention

Expert insights and a thromboprophylaxis protocol

April 7, 2020/Heart, Vascular and Thoracic/Research

PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve

1,000-patient prospective trial to start enrolling patients soon

September 26, 2019/Heart, Vascular and Thoracic/Research

Toward an Evidence-Based Approach to Anticoagulation After Bioprosthetic AVR

PARTNER 2 analysis finds few significant effects

June 18, 2015/Heart, Vascular and Thoracic/News & Insights

LAA Closure Device a Reality: Now What? (Video)

An expert’s take on FDA’s ‘appropriate rationale’ caveat

BackPage 1 of 2Next